Lantern Pharma Advances AI-Driven Cancer Trials with Strong Clinical Progress
August 25, 2025 — Lantern Pharma reports Q2 2025 results with clinical trial advancements, AI platform enhancements, and strong financial position extending funding into mid-2026.